SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-047076
Filing Date
2024-02-27
Accepted
2024-02-27 07:35:40
Documents
7
Effectiveness Date
2024-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 d783393ds8.htm S-8 31846
2 EX-5.1 d783393dex51.htm EX-5.1 8003
3 EX-23.2 d783393dex232.htm EX-23.2 1559
4 EX-FILING FEES d783393dexfilingfees.htm EX-FILING FEES 15759
5 GRAPHIC g783393g0223225156437.jpg GRAPHIC 1649
6 GRAPHIC g783393g0223225556708.jpg GRAPHIC 1649
7 GRAPHIC g783393g0223231905953.jpg GRAPHIC 6662
  Complete submission text file 0001193125-24-047076.txt   72390
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277381 | Film No.: 24682002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)